- POSITIVE
Annual Revenue Remus Pharma Mar-2026 Annual Revenue is Rs 101 Cr which is growth of 22.9% YoY.
- POSITIVE
Annual Net Profit Remus Pharma Mar-2026 Annual Net Profit is Rs 25 Cr which is growth of 24.2% YoY.
807.9012.90(1.62%)
700
NSE Volume
NSE 20 Nov, 2026 11:53 AM
Remus Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Remus Pharma competitor comparison and performance snapshot within industry
Remus Pharma annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|---|---|---|---|---|
29.3% | 39.3% | 100.8 | 82.1 | 67.2 | 46.6 | 25.4 | 19.2 | 12.8 | ||
Operating Exp. Ann. | 23.1% | 29.4% | 64.3 | 53.2 | 43.5 | 34.5 | 20.7 | 17.7 | 11.5 | |
Operating Profit Ann. | 41% | 106% | 29.7 | 26 | 20 | 10.6 | 4.1 | 0.8 | 0.4 | |
OPM Ann. % | 9.2% | 49.4% | 29.48% | 31.66% | 29.83% | 22.63% | 16.00% | 3.96% | 3.07% | |
24.3% | 30.4% | 67.6 | 55.4 | 44.7 | 35.2 | 20.9 | 17.9 | 11.7 | ||
EBITDA Ann. | 44.6% | 87% | 36.6 | 28.9 | 23.7 | 12.1 | 4.8 | 1.6 | 1.2 | |
EBITDA Ann. margin % | 11.7% | 34.8% | 36.26% | 35.20% | 35.33% | 26.01% | 18.83% | 8.16% | 9.73% | |
Interest Ann. | 44.2% | - | 0.6 | 0.4 | 0.3 | 0.2 | 0.1 | 0 | 0 | |
Depr. | 77.6% | 69.5% | 2.8 | 1.9 | 0.9 | 0.5 | 0.2 | 0.2 | 0.1 | |
PBT Ann. | 42.8% | 88.4% | 33.2 | 26.6 | 22.5 | 11.4 | 4.6 | 1.4 | 1.1 | |
Tax Ann. | 43.1% | 95.2% | 8.5 | 6.7 | 5.7 | 2.9 | 1.2 | 0.3 | 0.3 | |
42.7% | 89.9% | 24.7 | 19.9 | 16.8 | 8.5 | 3.4 | 1 | 0.8 | ||
Net Profit Ann. | 42.7% | 89.9% | 24.7 | 19.9 | 16.8 | 8.5 | 3.4 | 1 | 0.8 | |
NPM Ann. % | 11.7% | 36.4% | 26.29% | 25.13% | 26.48% | 18.88% | 13.69% | 5.56% | 6.80% | |
EPS Adj. latest Ann. | 42.9% | 87.8% | 21 | 16.9 | 14.3 | 7.2 | 2.9 | 0.9 | 0.7 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
22.8%
2Y CAGR
22.5%
3Y CAGR
29.3%
5Y CAGR
39.3%
Net Profit Ann.
1Y CHG
24.1%
2Y CAGR
21.3%
3Y CAGR
42.7%
5Y CAGR
89.9%
Operating Exp. Ann.
1Y CHG
20.9%
2Y CAGR
21.6%
3Y CAGR
23.1%
5Y CAGR
29.4%
Remus Pharma balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Remus Pharma Mar-2026 Total Shareholders Fund is Rs 326 Cr which is growth of 34.5% YoY.
- POSITIVE
Total Assets Remus Pharma Mar-2026 Total Assets is Rs 382 Cr which is growth of 36.3% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|---|---|---|---|---|
157.4% | 153.7% | 325.7 | 242.2 | 82.1 | 19.1 | 6.4 | 3.1 | 2 | ||
Minority Interest Liability Ann. | - | - | - | - | - | - | - | - | - | |
73.3% | 164% | 38.5 | 27 | 1.7 | 7.4 | 0.3 | 0.3 | 0.4 | ||
29.2% | 18.1% | 17.7 | 11.1 | 14.3 | 8.2 | 9.2 | 7.7 | 2.9 | ||
Total Capital Plus Liabilities Ann. | 122.4% | 102.9% | 381.9 | 280.3 | 98.1 | 34.7 | 15.9 | 11.1 | 5.3 | |
41.7% | 79.2% | 7.4 | 7.1 | 2.3 | 2.6 | 0.3 | 0.4 | 0.5 | ||
133.9% | 141.9% | 298.3 | 226.4 | 46.9 | 23.3 | 8.2 | 3.6 | 0.5 | ||
94.9% | 62% | 83.6 | 53.9 | 51.2 | 11.3 | 7.7 | 7.5 | 4.8 | ||
Total Assets Ann. | 122.4% | 102.9% | 381.9 | 280.3 | 98.1 | 34.7 | 15.9 | 11.1 | 5.3 | |
Contingent Liabilities plus Commitments Ann. | - | - | 0.3 | 76 | 94.4 | |||||
Bonus Equity Share Capital Ann. | 79.7% | - | 5.8 | 5.8 | 1.4 | 1 | 1 | |||
Non Current Investments Unquoted Book Value Ann. | 3.4% | - | 22.8 | 22.7 | 43.1 | 20.6 | 3.1 | |||
Current Investments Unquoted Book Value Ann. | - | - |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Assets Ann.
1Y CHG
36.2%
2Y CAGR
97.3%
3Y CAGR
122.4%
5Y CAGR
102.9%
Total Current Liabilities Ann.
1Y CHG
59.5%
2Y CAGR
11.3%
3Y CAGR
29.2%
5Y CAGR
18.1%
Total ShareHolders Funds Ann.
1Y CHG
34.5%
2Y CAGR
99.2%
3Y CAGR
157.4%
5Y CAGR
153.7%
Remus Pharma ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Book Value Per Share Remus Pharma Mar-2026 Book Value Per Share is 276 Rs which is growth of -32.8% YoY.
- POSITIVE
ROE Remus Pharma Mar-2026 ROE is 8% which is growth of 0.6% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|---|---|---|---|---|
BVSH Ann. | 16.2% | -38.1% | 276.5 | 411.2 | 557.1 | 176.4 | 64.3 | 3,046.1 | 2,020.3 | |
RoA Ann. % | -35.9% | -7% | 6.46% | 7.09% | 17.15% | 24.53% | 21.28% | 9.28% | 15.30% | |
ROE Ann. % | -44.5% | -25.8% | 7.58% | 8.21% | 20.49% | 44.43% | 52.64% | 33.67% | 40.17% | |
ROCE Ann. % | -40.4% | -25.9% | 9.28% | 10.03% | 27.27% | 43.94% | 69.08% | 41.48% | 47.78% | |
Total Debt to Total Equity Ann. | - | - | 0 | 0 | 0 | 0.4 | 0 | 0.1 | 0.2 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
ROE Ann. %
1Y CHG
-7.7%
2Y CAGR
-39.2%
3Y CAGR
-44.5%
5Y CAGR
-25.8%
RoA Ann. %
1Y CHG
-8.9%
2Y CAGR
-38.6%
3Y CAGR
-35.9%
5Y CAGR
-7%
Current Ratio Ann.
1Y CHG
-4.1%
2Y CAGR
14.3%
3Y CAGR
49.7%
5Y CAGR
36.3%
Remus Pharma cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEUTRAL
Cash From Operating Activity Remus Pharma Mar-2026 Cash From Operating Activity is Rs 0 Cr which is growth of 0% YoY.
- NEGATIVE
Net Cash Flow Remus Pharma Mar-2026 Net Cash Flow is Rs 0 Cr which is growth of -100.0% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|---|---|---|---|---|
46.1% | 64.4% | 15.6 | 2.4 | 5.3 | 5 | 2.8 | 1.3 | |||
Cash from Investing Act. Ann. | - | - | -12.4 | -20.9 | -15.2 | -4.6 | -3.1 | -0.6 | ||
Cash from Financing Act. Ann. | - | - | -1.4 | 39.3 | 11.8 | -0.2 | -0.1 | 0.1 | ||
81.7% | 17.6% | 1.8 | 20.8 | 1.9 | 0.3 | -0.4 | 0.8 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
550%
2Y CAGR
71.6%
3Y CAGR
46.1%
5Y CAGR
64.4%
